Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
If publishing online, please link to the original URL of the story.
Maintain any tagline at the bottom of the story.
With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.
Maintain correct caption information.
Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
Do not digitally alter images.
Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.
Do not state or imply that donations to any third-party organization support Direct Relief's work.
Republishers may not sell Direct Relief's content.
Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.
For any additional questions about republishing Direct Relief content, please email the team here.
A patient at Avenal Community Health Center described watching his sixth friend die from overdose to Dr. Khuong Phui in May. He said the deceased had been confused, then unresponsive and had shallow to nonexistent breathing.
The patient, a heroin user, was at the federally qualified health center for treatment. Phui sent him home with naloxone, an overdose reversal drug, just in case. Two more patients with similar stories left the clinic the same week.
The overdose reversal drug was one of 50,000 doses sent across the United States through a four-year partnership with Direct Relief and Pfizer Pharmaceuticals. The pair have agreed to provide naloxone to combat overdose deaths in the opioid epidemic, as stories from patients like Phui’s have become more common.
Though California is instituting new policies that emphasize community collaboration, doctor accountability measures and funding to combat the epidemic, many health clinics were financially unprepared for the influx of assistance needed. Funding from the federal government wasn’t guaranteed until the President’s National Drug Control Budget was released in May.
Dr. Kimberly Johnson of the Substance Abuse and Mental Health Services Association confirmed fentanyl’s rise in popularity over the last three years. Its use is congruent with the jump in overdose death rates.
“People who don’t know the strength of what they are getting leads to a higher rate of overdose,” said Johnson. “They may be buying what they think is heroin. Heroin is never 100 percent pure, it’s always mixed with something.”
As the epidemic worsens, spurring national attention on prevention and recovery methods, naloxone is one treatment that has remained constant. The New England Journal of Medicine said the FDA first approved the life-saving medication in 1971 and generic brands have been available to the public since 1985. While generic brands can be found at a local pharmacy for about $30, name-brand products have experienced serious price hikes, but the product provided by Pfizer and Direct Relief retails for about $15 a dose.
But health clinics aren’t just trying to prevent death. In California, medically assisted treatment programs are encouraged to curve and control addiction. These programs provide patients who suffer from substance abuse disorder with therapy and a prescription of a weakened opioid to help with withdrawal.
Avenal Community Health has two waived physicians for their medically assisted treatment program and prescribes suboxone to patients who are trying to control their addiction. The clinic launched the program with a community partner who offers therapy and rehabilitation services.
The health center is in Kings County, California, which has yet to submit a county implementation plan with the state. California is encouraging local stakeholders to be proactive in substance use disorder prevention and recovery treatment. Under this initiative, Medi-Cal (California’s version of Medicaid) patients have more affordable access to treatment. According to the state’s Department of Health Care Services, 19 counties have implementation plans that have already been approved. Eight more, including a multi-county plan covering nine areas, are awaiting approval from the state.
Additionally, Avenal doctors are avid users of the California Controlled Substance Utilization Review and Evaluation System, also known as CURES. CURES database allows doctors to track patient prescriptions across medical systems, helpful for doctors who treat non-regular patients for pain. According to the California Department of Justice, the state was the first in the country to begin tracking this practice as a counter diversion tool for law enforcement. Almost every state in the country now has a similar system.
Anyone able to write a prescription in the state is required to register with CURES. However, DOJ representatives say those able to write prescriptions are not required to use the system for their patients. That may change in early 2018. CURES is currently state-funded, but in President Donald Trump’s National Drug Control Budget for 2018, a $12 million increase to state grants was approved for prescription drug monitoring programs. The budget also calls for increases in funding for medically assisted treatment programs and $103 million in drug enforcement efforts through organized crime.
(Editor’s note: This story is the third in a series. Earlier stories can be found below.)